Cleave Therapeutics
San Francisco
About Cleave Therapeutics
Cleave Therapeutics develops oncology pharmaceuticals designed to target neurodengeneration and pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival, enabling patients to get cured from cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $101.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Aug 2019)
- Website: cleavetherapeutics.com
- Phone: (415) 562-8117
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/cleave-therapeutics-72510 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.